Compounds > 1,10-phenanthroline-platinum(ii)-ethylenediamine
Page last updated: 2024-09-05

1,10-phenanthroline-platinum(ii)-ethylenediamine and Lung Neoplasms

1,10-phenanthroline-platinum(ii)-ethylenediamine has been researched along with Lung Neoplasms in 1 studies

Research

Studies (1)

TimeframeStudies, this research(%)All Research%
pre-19900 (0.00)18.7374
1990's0 (0.00)18.2507
2000's0 (0.00)29.6817
2010's0 (0.00)24.3611
2020's1 (100.00)2.80

Authors

AuthorsStudies
Barbacid, M; Beirnaert, E; Claes, F; Duran-Romaña, R; Garcia, T; Houben, B; Janssen, K; Khodaparast, L; Konstantoulea, K; Lampi, Y; Louros, N; Maragkou, K; Musteanu, M; Nys, M; Ramakers, M; Rousseau, F; Schymkowitz, J; Scorneaux, B; Van de Velde, D; van der Kant, R; Verniers, J; Wehbi, VL1

Other Studies

1 other study(ies) available for 1,10-phenanthroline-platinum(ii)-ethylenediamine and Lung Neoplasms

ArticleYear
Exploiting the intrinsic misfolding propensity of the KRAS oncoprotein.
    Proceedings of the National Academy of Sciences of the United States of America, 2023, 02-28, Volume: 120, Issue:9

    Topics: Animals; Cell Line, Tumor; Lung Neoplasms; Mice; Mutation; Oncogene Proteins; Protein Folding; Proto-Oncogene Proteins p21(ras)

2023